Skip to main content

Vitamin B12 Supplementation in Urinary Diversion

Vitamin B12 deficiency is the best-characterized long-term nutritional complication of urinary reconstruction with ileal segments, a silent, slow-onset, and partly irreversible problem that the reconstructive urologist should plan to monitor for the rest of the patient's life. Intrinsic-factor-dependent B12 absorption occurs in the terminal ileum; a small proportion of a high oral dose can also be absorbed passively elsewhere.[4][5] Hepatic B12 stores can delay clinical manifestations for up to 10 years after deficiency begins;[15] in an ileocolic neobladder series, one patient with malabsorptive deficiency had neurological symptoms 53 months after surgery.[6] By then, neurological damage (subacute combined degeneration, peripheral neuropathy, cognitive change) may not fully reverse with repletion; monitor B12 over time and treat confirmed or clinically suspected deficiency promptly.[5][6][14]

In 303 men with infertility, serum B12 was associated with total testosterone; semen-quality evidence is heterogeneous, and cross-sectional erectile-dysfunction studies report B12 associations in opposite directions.[2][3][17][18] This article covers both: the diversion-surveillance story first, then the andrology adjunct.

For adjacent long-term diversion topics see Mucus management and Urinary acidifiers & alkalinizers.

Why Ileal Diversion Causes B12 Deficiency​

Anatomic factorEffect on B12 absorption
Extensive terminal ileal resection or prior ileal surgeryIncreased risk of deficiency; gastroenterology guidance advises B12 monitoring in this group[4]
Loss of ~ 50 cm of terminal ileumHistorical cohort: reduced absorption in 20/25 Kock pouch patients versus 0/29 ileal-neobladder patients; both groups included patients with low serum B12.[7] In a later series, no patient with 50–60 cm of ileum had a low B12 or abnormal Schilling test, whereas patients with an ileocecal segment did[8]
Use of ileocecal segment (Indiana, Mainz)Potential loss of distal-ileal absorptive function; assess the actual bowel segment and remaining anatomy[8]
Colonic neobladder (ascending, sigmoid)Avoids direct loss of ileal absorption if ileum is preserved; other causes of B12 deficiency remain possible[9]

In Ganesan's 70-patient urinary-reconstruction series, ileocecal segment use was associated with B12 malabsorption, while no patient in the 50–60 cm ileal group had a low B12 level or abnormal Schilling test; plan surveillance around the bowel segment used.[8][9]

Historical Series by Diversion Type​

These small cohorts used different tests and follow-up durations. Schilling results measure absorption.

DiversionIleal length usedLow serum B12Schilling-confirmed malabsorptionTypical latency
Ileal conduit15–20 cmUncommon in early series (0/25 below 200 pg/mL);[11] five low B12 values in another series came from a combined group of ileal conduits and enterocystoplasties[8]VariableOften years; tissue deficiency more common than serum levels suggest[10]
Ileal neobladder (Studer)40–60 cm13.6%[9]Not routinely tested9 mo – 3 yr
Kock pouch70 cm distal ileum in Olofsson[31]4/25 (16%) had low serum B12 at 8–25 mo[7]; about 10% developed true deficiency in a separate 97-patient series sampled up to 18 yr[31]20/25 (80%) had reduced absorption at 8–25 mo[7]; 3/9 (33%) in another series[11]Pannek mean follow-up 13 mo; long-term measurements extend to 18 yr in Olofsson[7][31]
Ileocolic neobladder (including Mainz)Ileocecal segment3/18 (16.6%) in the Mainz cohort[9]; 6/24 (25%) in another ileocolic cohort[6]3/24 (13%) in the latter cohort[6]Mainz: low values at 5–6 yr[9]; other cohort: follow-up 6–53 mo[6]
Indiana pouchIleocecal segmentNone below 200 pg/mL in one series[11]67% (4/6)[11]Variable
Colonic neobladder0 cm ileum0/39 (9 ascending, 30 sigmoid) had low serum B12[9]Not reportedNo low values; study-wide follow-up 3 mo–11 yr (mean 3.4 yr)[9]
Pediatric ileal enterocystoplasty15–25 cmAt ≥7 yr, 6/29 (21%) low and 12/29 (41%) low-normal[12]; in a separate series, 16/128 (13%) low and 36/128 (28%) low or low-normal at mean follow-up 83 mo[13]Not routineRisk rises after 7 yr

Serum B12 alone underestimates the true burden. In Sagalowsky & Frenkel 2002, complete cobalamin profiles (serum B12 plus MMA plus homocysteine) in 41 diversion patients showed tissue deficiency prevalence significantly higher than serum B12 alone would suggest.[10]

Clinical Manifestations — What Not to Miss​

B12 deficiency produces two categories of damage with very different reversibility.[5]

Hematologic (typically reversible)

  • Megaloblastic anemia, macrocytosis, hypersegmented neutrophils, pancytopenia
  • No patient in the major urologic series developed frank megaloblastic anemia.[6][9][11]

Neurologic (potentially irreversible)

  • Subacute combined degeneration of the spinal cord (dorsal and lateral column demyelination)
  • Peripheral neuropathy: paresthesias, numbness, gait ataxia
  • Cognitive dysfunction, dementia, psychiatric change
  • One patient in Steiner et al.'s ileocolic neobladder series presented with neurologic symptoms at 53 months postoperatively, the only symptomatic case in that cohort and a cautionary tale about long latency[6]
  • Neurologic B12 deficiency can occur without anemia or macrocytosis; do not use a normal blood count to exclude it[5]

Other: glossitis, infertility, venous thromboembolism (including cerebral venous sinus thrombosis).[5]

Neurologic damage may not fully reverse with repletion.

Monitoring and Screening​

The EAU bladder cancer guideline states that B12 should be measured annually after cystectomy with bowel diversion, citing low levels in 17% of patients with bowel diversion.[14] This is guideline text rather than a graded recommendation, and the panel's follow-up table records no consensus on B12 timing.[14] NCCN post-cystectomy follow-up specifies annual B12 testing after the first year, based on clinical judgment (category 2A).[26] The AUA/ASCO/SUO guideline discussion advises assessing B12 during follow-up, because the risk of deficiency and neurologic damage is increased after resection of more than 60 cm of ileum and when the terminal ileum is used.[25] In neurogenic bowel-segment reconstruction, the AUA/SUFU guideline text (Statement 58 discussion) advises monitoring B12 over time, with supplementation if appropriate, when terminal ileum is used.[21]

  • Record the actual resected or bypassed ileal segment, baseline nutritional status and other causes such as dietary deficiency, gastric disease or medication use.
  • Use the laboratory's total or active-B12 thresholds; consider MMA for an indeterminate result with compatible symptoms. Interpret MMA with renal function because renal impairment can raise it independently. Homocysteine is less specific.[10][15][22]
  • Schilling testing is historical, not a routine contemporary diagnostic step. Do not wait for it before treating clinically significant deficiency.
  • Pediatric cohorts show rising risk with longer follow-up; plan monitoring with the pediatric reconstruction team and test earlier for symptoms, nutritional concerns or extensive ileal loss.[12][13]
  • When neurologic or significant hematologic manifestations suggest deficiency, arrange prompt treatment and clinical follow-up.[5][22]

Replacement: Choose the Route for the Cause and Severity​

Parenteral replacement is appropriate for clinically important malabsorption, neurologic disease or unreliable oral response or adherence. Typical schedules use 1 mg IM three times weekly for 2 weeks without neurologic deficits; with neurologic deficits, the cited schedule is every other day for up to 3 weeks or until no further improvement is noted.[15] NICE NG239 does not set an injection schedule; it defers to the product's summary of product characteristics and recommends lifelong IM replacement after complete terminal ileal resection.[22] The loading and maintenance regimen depends on the selected cyanocobalamin or hydroxocobalamin product and local protocol; a monthly maintenance dose is not an adequate loading instruction for a symptomatic patient.[4][16][22]

High-dose oral therapy can work through passive absorption. The 2018 Cochrane review (3 trials, 153 participants) found low-certainty evidence for comparable short-term serum-level correction with oral and IM therapy, but the review did not provide usable evidence on clinical neurologic outcomes.[23]

The OB12 trial (2020; 283 adults aged ≥65 years) found oral B12 1 mg daily for 8 weeks noninferior to IM therapy for serum normalization at 8 weeks. Oral treatment then fell to 1 mg weekly; noninferiority was not established at 52 weeks.[24]

NICE's adult guideline recommends lifelong IM replacement after complete terminal ileal resection or total gastrectomy, or when autoimmune gastritis is the cause or suspected cause of vitamin B12 deficiency, and consideration of IM therapy for other malabsorption. Symptoms may begin to improve within 2 weeks but can take up to 3 months. Offer an initial follow-up at 3 months or earlier according to symptom severity, or at 1 month during pregnancy or breastfeeding; assess symptoms at follow-up and do not repeat the initial diagnostic test during IM replacement.[22] If oral therapy is chosen for malabsorption, use at least 1 mg/day and assess response.[22]

Vanderbrink's pediatric ileocystoplasty cohort reported short-term serum improvement with 250 µg/day oral therapy; it provides no adult-dose or pediatric neurologic-efficacy estimate.[13] In a later cohort from the same center, 4/23 (17%) had normal serum B12 at final measurement a mean 49 months after the first abnormal result; replacement was documented in 16/23 (14 oral, 2 IM).[27] Monitoring or empirical supplementation has been proposed after diversion.[10]

B12 and Male Reproductive / Sexual Health​

Erectile dysfunction​

  • Xu 2021 (n = 184). ED patients had lower B12 levels (256 versus 337.5 pg/mL; p < 0.05)[3]
  • Chen 2019 (n = 1,381, China). Paradoxically found higher B12 in men with ED (718.5 versus 688.7 pg/mL; p = 0.015); higher B12 associated with mild ED (OR 1.62)[17]; the study was cross-sectional
  • Homocysteine is a proposed link. B12 deficiency can raise homocysteine, and elevated homocysteine may impair endothelial nitric-oxide signaling.[3][17]

Male infertility and androgen profile​

  • Rastegar Panah 2024 (n = 303 infertile men). Serum B12 positively associated with total testosterone (ρ = 0.19; p = 0.001); highest B12 tertile had 56% lower odds of testosterone deficiency (adjusted OR 0.44; 95% CI 0.22–0.87)[2]
  • Banihani 2017 review. Describes heterogeneous clinical and preclinical evidence concerning sperm count, motility and DNA damage, with proposed pathways including reduced homocysteine toxicity, reduced oxidative stress, reduced NO-mediated damage, and anti-inflammatory effects[18]
  • Mathew 2026 review. B12 status may influence reproductive outcomes through one-carbon metabolism and oxidative-stress pathways, but causal effects on human gamete quality remain unconfirmed.[19]
  • B12 deficiency is listed as an uncommon cause of infertility in the NEJM clinical-practice review[5]

Practical takeaway. Investigate B12 when symptoms or nutritional or anatomic risk justify it, particularly after ileal resection or diversion.

Other Urologic Considerations​

Metabolic acidosis after ileal diversion​

Ileal urinary diversion can lead to B12 deficiency and, through ammonium-chloride reabsorption and bicarbonate loss by bowel mucosa, hyperchloremic metabolic acidosis; chronic acidosis can contribute to bone demineralization.[1] See Urinary acidifiers & alkalinizers for oral bicarbonate dosing.

Bone health​

In a meta-analysis of four prospective studies of adults and older adults (7,475 participants), each 50 pmol/L higher B12 concentration was associated with a borderline 4% lower fracture risk (RR 0.96, 95% CI 0.92–1.00), while chronic acidosis after bowel diversion can contribute to bone demineralization; monitor B12 and acid–base status as separate follow-up needs.[30][1][14]

Pediatric considerations​

  • Adequate B12 is important for childhood neurodevelopment; requirements are age-specific[12]
  • 28% of pediatric ileocystoplasty patients had low or low-normal B12 at mean follow-up of 83 mo[13]
  • Patients after childhood bowel reconstruction. Folate was low in 4/27 (14.8%) tested patients; assess nutritional status and counsel women of childbearing age.[20] When B12 and folate deficiency coexist, replace B12 first to prevent neurologic injury.[20][15]

Practical Clinical Summary​

ScenarioReview and action
Cystectomy with bowel diversionEAU advises annual B12 measurement in its guideline text.[14] NCCN specifies annual testing after the first year based on clinical judgment (category 2A).[26] Investigate and replace deficiency according to cause and severity.
Complete terminal ileal resectionAdult NICE guidance recommends lifelong IM replacement; distinguish this from partial ileal use.[22]
Pediatric augmentationFor children with neurogenic lower urinary tract dysfunction after augmentation cystoplasty, the 2023 Canadian guideline recommends yearly serum chemistries including B12 and lifelong follow-up .[29] Use an age- and presentation-appropriate replacement regimen.[12][13]
Colonic reconstruction with preserved ileumDirect ileal loss is avoided.[9]
Sexual/fertility concernsTreat proven deficiency.[22]

See Also​

References​

1. Roth JD, Koch MO. "Metabolic and nutritional consequences of urinary diversion using intestinal segments to reconstruct the urinary tract." Urol Clin North Am. 2018;45(1):19–24. doi:10.1016/j.ucl.2017.09.007

2. Rastegar Panah M, Jarvi K, Lo K, El-Sohemy A. "Vitamin B12 is associated with higher serum testosterone concentrations and improved androgenic profiles among men with infertility." J Nutr. 2024;154(9):2680–2687. doi:10.1016/j.tjnut.2024.06.013

3. Xu J, Xu Z, Ge N, et al. "Association between folic acid, homocysteine, vitamin B12 and erectile dysfunction — a cross-sectional study." Andrologia. 2021;53(11):e14234. doi:10.1111/and.14234

4. Hashash JG, Elkins J, Lewis JD, Binion DG. "AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review." Gastroenterology. 2024;166(3):521–532. doi:10.1053/j.gastro.2023.11.303

5. Stabler SP. "Vitamin B12 deficiency." N Engl J Med. 2013;368(2):149–160. doi:10.1056/NEJMcp1113996

6. Steiner MS, Morton RA, Marshall FF. "Vitamin B12 deficiency in patients with ileocolic neobladders." J Urol. 1993;149(2):255–257. doi:10.1016/s0022-5347(17)36049-4

7. Pannek J, Haupt G, Schulze H, Senge T. "Influence of continent ileal urinary diversion on vitamin B12 absorption." J Urol. 1996;155(4):1206–1208. doi:10.1016/s0022-5347(01)66217-7

8. Ganesan T, Khadra MH, Wallis J, Neal DE. "Vitamin B12 malabsorption following bladder reconstruction or diversion with bowel segments." ANZ J Surg. 2002;72(7):479–482. doi:10.1046/j.1445-2197.2002.02460.x

9. Fujisawa M, Gotoh A, Nakamura I, et al. "Long-term assessment of serum vitamin B12 concentrations in patients with various types of orthotopic intestinal neobladder." Urology. 2000;56(2):236–240. doi:10.1016/s0090-4295(00)00638-5

10. Sagalowsky AI, Frenkel EP. "Cobalamin profiles in patients after urinary diversion." J Urol. 2002;167(4):1696–1700. doi:10.1016/s0022-5347(05)65180-4

11. Terai A, Okada Y, Shichiri Y, et al. "Vitamin B12 deficiency in patients with urinary intestinal diversion." Int J Urol. 1997;4(1):21–25. doi:10.1111/j.1442-2042.1997.tb00133.x

12. Rosenbaum DH, Cain MP, Kaefer M, et al. "Ileal enterocystoplasty and B12 deficiency in pediatric patients." J Urol. 2008;179(4):1544–1547. doi:10.1016/j.juro.2007.11.089

13. Vanderbrink BA, Cain MP, King S, et al. "Is oral vitamin B12 therapy effective for vitamin B12 deficiency in patients with prior ileocystoplasty?" J Urol. 2010;184(4 Suppl):1781–1785. doi:10.1016/j.juro.2010.05.049

14. European Association of Urology. Muscle-invasive and metastatic bladder cancer: follow-up. 2026. Guideline. Accessed September 12, 2026.

15. Langan RC, Goodbred AJ. "Vitamin B12 deficiency: recognition and management." Am Fam Physician. 2017;96(6):384–389. PMID 28925645

16. Mauermann ML, Staff NP. "Peripheral neuropathy." JAMA. 2026;335(3):255–266. doi:10.1001/jama.2025.19400

17. Chen Y, Li J, Li T, et al. "Association between homocysteine, vitamin B12, folic acid and erectile dysfunction: a cross-sectional study in China." BMJ Open. 2019;9(5):e023003. doi:10.1136/bmjopen-2018-023003

18. Banihani SA. "Vitamin B12 and semen quality." Biomolecules. 2017;7(2):42. doi:10.3390/biom7020042

19. Mathew AR, Selita E, Regano C, et al. "Vitamin B12 and reproductive health: clinical insights, emerging mechanistic understanding, and nutritional aspects." Mol Reprod Dev. 2026;93(2):e70088. doi:10.1002/mrd.70088

20. Kalloo NB, Jeffs RD, Gearhart JP. "Long-term nutritional consequences of bowel segment use for lower urinary tract reconstruction in pediatric patients." Urology. 1997;50(6):967–971. doi:10.1016/S0090-4295(97)00470-6

21. AUA/SUFU. Adult neurogenic lower urinary tract dysfunction guideline, statement 58 and discussion. 2021. Guideline.

22. NICE. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239). 2024 (minor update December 2024), recommendations 1.2–1.6. Guideline. Accessed September 12, 2026.

23. Wang H, Li L, Qin LL, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018;3:CD004655. doi:10.1002/14651858.CD004655.pub3.

24. Sanz-Cuesta T, et al. "Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12)." BMJ Open. 2020;10:e033687. doi:10.1136/bmjopen-2019-033687.

25. Holzbeierlein J, Bixler BR, Buckley DI, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024). J Urol. 2024;212(1):3-10. doi:10.1097/JU.0000000000003981

26. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer. Version 3.2026. August 6, 2026. BL-E 3–4 of 6; Discussion MS-17, MS-28. Guideline.

27. Keenan A, Whittam B, Rink R, et al. "Vitamin B12 deficiency in patients after enterocystoplasty." J Pediatr Urol. 2015;11(5):273.e1–273.e5. doi:10.1016/j.jpurol.2015.04.026

28. European Association of Urology. EAU Guidelines on Sexual and Reproductive Health: Management of Erectile Dysfunction. 2026. Guideline.

29. Chua ME, Yadav P, Wang PZT, et al. "2023 Canadian Urological Association/Pediatric Urologists of Canada guideline: Pediatric patients with neurogenic lower urinary tract dysfunction: Full-text version." Can Urol Assoc J. 2023;17(10):E338–E357. doi:10.5489/cuaj.8390

30. van Wijngaarden JP, Doets EL, Szczecińska A, et al. "Vitamin B12, folate, homocysteine, and bone health in adults and elderly people: a systematic review with meta-analyses." J Nutr Metab. 2013;2013:486186. doi:10.1155/2013/486186

31. Olofsson G, Kilander A, Lindgren A, Ung KA, Jonsson O. "Vitamin B12 metabolism after urinary diversion with a Kock ileal reservoir." Scand J Urol Nephrol. 2001;35(5):382–387. doi:10.1080/003655901753224440